Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Down 82.1% in July

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a large decline in short interest in July. As of July 31st, there was short interest totaling 228,600 shares, adeclineof82.1% from the July 15th total of 1,279,300 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Ascentage Pharma Group International Price Performance

Shares of ASPHF opened at $5.83 on Friday. The stock’s 50 day moving average is $5.82 and its two-hundred day moving average is $5.83. Ascentage Pharma Group International has a twelve month low of $5.42 and a twelve month high of $6.45.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.